estrogen

Assessing Estrogen-Induced Proliferative Response in an Endometrial Cancer Cell Line Using a Universally Applicable Methodological Guide
Christina Parkes, Areege Kamal, Anthony J. Valentijn, Rafah Alnafakh, Stephane R. Gross, Roger Barraclough, Diana Moss, John Kirwan, Dharani K. Hapangama

International Journal of Gynecologic Cancer Jan 2018, 28 (1) 122-133; DOI: 10.1097/IGC.0000000000001121
Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines
Lingyun Yang, Feng Huang, Jiandong Mei, Xun Wang, Qiuyang Zhang, Hongjing Wang, Mingrong Xi, Zongbing You

International Journal of Gynecologic Cancer Feb 2017, 27 (2) 196-205; DOI: 10.1097/IGC.0000000000000875
The G Protein–Coupled Receptor GPR30 Mediates the Nontranscriptional Effect of Estrogen on the Activation of PI3K/Akt Pathway in Endometrial Cancer Cells
Xin Ge, Ruixia Guo, Yuhuan Qiao, Yancai Zhang, Jia Lei, Xinyan Wang, Liuxia Li, Dongmei Hu

International Journal of Gynecologic Cancer Jan 2013, 23 (1) 52-59; DOI: 10.1097/IGC.0b013e31827912b8
ATL
Hedva Lerman, Shikma Bar-On, Limor Helpman, Einat Even-Sapir, Dan Grisaru

International Journal of Gynecologic Cancer Sep 2012, 22 (7) 1187-1191; DOI: 10.1097/IGC.0b013e31825bedc7
Mutual Contribution of Pten and Estrogen to Endometrial Carcinogenesis in a Pten^loxP/loxP Mouse Model
Fumitaka Saito, Hironori Tashiro, Yoko To, Hideyuki Ohtake, Takashi Ohba, Akira Suzuki, Hidetaka Katabuchi

International Journal of Gynecologic Cancer Nov 2011, 21 (8) 1343-1349; DOI: 10.1097/IGC.0b013e31822d2a8a
Significance of Nuclear p-Akt in Endometrial Carcinogenesis: Rapid Translocation of p-Akt Into the Nucleus by Estrogen, Possibly Resulting in Inhibition of Apoptosis
Naoya Abe, Jun Watanabe, Shinpei Tsunoda, Hiroyuki Kuramoto, Isao Okayasu

International Journal of Gynecologic Cancer Jan 2011, 21 (2) 194-202; DOI: 10.1097/IGC.0b013e318207964c
Aromatase inhibitors in ovarian cancer: is there a role?
Y. F. Li, W. Hu, S. Q. Fu, J. D. Li, J. H. Liu, J. J. Kavanagh

International Journal of Gynecologic Cancer Jul 2008, 18 (4) 600-614; DOI: 10.1136/ijgc-00009577-200807000-00002
Hormonal therapy in ovarian cancer
H. Zheng, J. J. Kavanagh, W. Hu, Q. Liao, S. Fu

International Journal of Gynecologic Cancer Feb 2007, 17 (2) 325-338; DOI: 10.1111/j.1525-1438.2006.00749.x
Upregulation of CD44 expression by interleukins 1, 4, and 13, transforming growth factor-β1, estrogen, and progestogen in human cervical adenocarcinoma cell lines
E. M. Ibrahim, R. L. Stewart, K. Corke, A. D. Blackett, J. A. Tidy, M. Wells

International Journal of Gynecologic Cancer Jul 2006, 16 (4) 1631-1642; DOI: 10.1136/ijgc-00009577-200607000-00022
Effects of 17β-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines
M. Ruutu, N. Wahlroos, K. Syrjänen, B. Johansson, S. Syrjänen

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1261-1268; DOI: 10.1136/ijgc-00009577-200605000-00047

Main menu

estrogen

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

estrogen

Pages